What is the optimal first line antiretroviral therapy in resource-limited settings?
- PMID: 22904690
- PMCID: PMC3419160
- DOI: 10.1371/journal.pmed.1001291
What is the optimal first line antiretroviral therapy in resource-limited settings?
Abstract
A perspective by Chris Kenyon and Robert Colebunders discusses policy implications for use of first line antiretroviral therapies in resource-limited settings, emerging from a new research study conducted by Campbell and colleagues.
Conflict of interest statement
The authors have declared that no competing interests exist.
Comment on
-
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.PLoS Med. 2012;9(8):e1001290. doi: 10.1371/journal.pmed.1001290. Epub 2012 Aug 14. PLoS Med. 2012. PMID: 22936892 Free PMC article. Clinical Trial.
References
-
- Medecins Sans Frontieres (n.d.) Access to antiretrovirals; Untangling the Web of ARV Price Reductions. Available: http://utw.msfaccess.org. Accessed 30 May 2012.
-
- WHO (2010) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach – 2010 revision. World Health Organization - PubMed
-
- Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, et al. (2012) Efficacy and safety of three antiretroviral regimens for initial treatment of hiv-1: a randomized clinical trial in diverse multinational settings. PLoS Med 9: e1001290 10.1371/journal.pmed.1001290. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical